Back to Authors

Verdugo, Maria E.

A5113792916 | I2948539688

Mayo Clinic

AbbVie (United States)

Citations 2

Phase I venetoclax monotherapy for relapsed/refractory multiple myeloma.

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8032-8032

10.1200/jco.2016.34.15_suppl.8032

Phase Ib venetoclax combined with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 8011-8011

10.1200/jco.2016.34.15_suppl.8011